Literature DB >> 25448007

Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties.

Mario A Saporta1, Vu Dang2, Dmitri Volfson2, Bende Zou3, Xinmin Simon Xie3, Adijat Adebola4, Ronald K Liem4, Michael Shy5, John T Dimos2.   

Abstract

OBJECTIVE: Charcot-Marie-Tooth (CMT) disease is a group of inherited peripheral neuropathies associated with mutations or copy number variations in over 70 genes encoding proteins with fundamental roles in the development and function of Schwann cells and peripheral axons. Here, we used iPSC-derived cells to identify common pathophysiological mechanisms in axonal CMT.
METHODS: iPSC lines from patients with two distinct forms of axonal CMT (CMT2A and CMT2E) were differentiated into spinal cord motor neurons and used to study axonal structure and function and electrophysiological properties in vitro.
RESULTS: iPSC-derived motor neurons exhibited gene and protein expression, ultrastructural and electrophysiological features of mature primary spinal cord motor neurons. Cytoskeletal abnormalities were found in neurons from a CMT2E (NEFL) patient and corroborated by a mouse model of the same NEFL point mutation. Abnormalities in mitochondrial trafficking were found in neurons derived from this patient, but were only mildly present in neurons from a CMT2A (MFN2) patient. Novel electrophysiological abnormalities, including reduced action potential threshold and abnormal channel current properties were observed in motor neurons derived from both of these patients.
INTERPRETATION: Human iPSC-derived motor neurons from axonal CMT patients replicated key pathophysiological features observed in other models of MFN2 and NEFL mutations, including abnormal cytoskeletal and mitochondrial dynamics. Electrophysiological abnormalities found in axonal CMT iPSC-derived human motor neurons suggest that these cells are hyperexcitable and have altered sodium and calcium channel kinetics. These findings may provide a new therapeutic target for this group of heterogeneous inherited neuropathies.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Axonal Charcot–Marie–Tooth disease; Axonal transport; Electrophysiology; Induced pluripotent stem cells; Inherited Neuropathies; Motor neurons

Mesh:

Substances:

Year:  2014        PMID: 25448007      PMCID: PMC4262589          DOI: 10.1016/j.expneurol.2014.10.005

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  34 in total

1.  Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A.

Authors:  Stephan Züchner; Irina V Mersiyanova; Maria Muglia; Nisrine Bissar-Tadmouri; Julie Rochelle; Elena L Dadali; Mario Zappia; Eva Nelis; Alessandra Patitucci; Jan Senderek; Yesim Parman; Oleg Evgrafov; Peter De Jonghe; Yuji Takahashi; Shoij Tsuji; Margaret A Pericak-Vance; Aldo Quattrone; Esra Battaloglu; Alexander V Polyakov; Vincent Timmerman; J Michael Schröder; Jeffery M Vance; Esra Battologlu
Journal:  Nat Genet       Date:  2004-04-04       Impact factor: 38.330

2.  Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration.

Authors:  Albert L Misko; Yo Sasaki; Elizabeth Tuck; Jeffrey Milbrandt; Robert H Baloh
Journal:  J Neurosci       Date:  2012-03-21       Impact factor: 6.167

3.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

4.  Mutations in the neurofilament light gene linked to Charcot-Marie-Tooth disease cause defects in transport.

Authors:  Raül Pérez-Ollé; Miguel A López-Toledano; Dmitry Goryunov; Noemi Cabrera-Poch; Leonidas Stefanis; Kristy Brown; Ronald K H Liem
Journal:  J Neurochem       Date:  2005-05       Impact factor: 5.372

5.  Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study.

Authors:  E Nelis; C Van Broeckhoven; P De Jonghe; A Löfgren; A Vandenberghe; P Latour; E Le Guern; A Brice; M L Mostacciuolo; F Schiavon; F Palau; S Bort; M Upadhyaya; M Rocchi; N Archidiacono; P Mandich; E Bellone; K Silander; M L Savontaus; R Navon; H Goldberg-Stern; X Estivill; V Volpini; W Friedl; A Gal
Journal:  Eur J Hum Genet       Date:  1996       Impact factor: 4.246

6.  Phenotypic analysis of neurofilament light gene mutations linked to Charcot-Marie-Tooth disease in cell culture models.

Authors:  Raul Perez-Olle; Sidonie T Jones; Ronald K H Liem
Journal:  Hum Mol Genet       Date:  2004-07-28       Impact factor: 6.150

7.  The clinical features of hereditary motor and sensory neuropathy types I and II.

Authors:  A E Harding; P K Thomas
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

8.  Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease.

Authors:  Edith Passage; Jean Chrétien Norreel; Pauline Noack-Fraissignes; Véronique Sanguedolce; Josette Pizant; Xavier Thirion; Andrée Robaglia-Schlupp; Jean François Pellissier; Michel Fontés
Journal:  Nat Med       Date:  2004-03-21       Impact factor: 53.440

9.  Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice.

Authors:  Jason J Kuo; Martijn Schonewille; Teepu Siddique; Annet N A Schults; Ronggen Fu; Peter R Bär; Roberta Anelli; C J Heckman; Alfons B A Kroese
Journal:  J Neurophysiol       Date:  2003-10-01       Impact factor: 2.714

10.  Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.

Authors:  Guida Landouré; Anselm A Zdebik; Tara L Martinez; Barrington G Burnett; Horia C Stanescu; Hitoshi Inada; Yijun Shi; Addis A Taye; Lingling Kong; Clare H Munns; Shelly S Choo; Christopher B Phelps; Reema Paudel; Henry Houlden; Christy L Ludlow; Michael J Caterina; Rachelle Gaudet; Robert Kleta; Kenneth H Fischbeck; Charlotte J Sumner
Journal:  Nat Genet       Date:  2009-12-27       Impact factor: 38.330

View more
  35 in total

1.  The tethering function of mitofusin2 controls osteoclast differentiation by modulating the Ca2+-NFATc1 axis.

Authors:  Anna Ballard; Rong Zeng; Allahdad Zarei; Christine Shao; Linda Cox; Hui Yan; Antonietta Franco; Gerald W Dorn; Roberta Faccio; Deborah J Veis
Journal:  J Biol Chem       Date:  2020-03-12       Impact factor: 5.157

2.  A human cellular model to study peripheral myelination and demyelinating neuropathies.

Authors:  Mario A Saporta; Michael E Shy
Journal:  Brain       Date:  2017-04-01       Impact factor: 13.501

3.  Enzymatically crosslinked gelatin-laminin hydrogels for applications in neuromuscular tissue engineering.

Authors:  Rachel R Besser; Annie C Bowles; Ahmad Alassaf; Daniel Carbonero; Isabella Claure; Ellery Jones; Joseph Reda; Laura Wubker; Wyndham Batchelor; Noël Ziebarth; Risset Silvera; Aisha Khan; Renata Maciel; Mario Saporta; Ashutosh Agarwal
Journal:  Biomater Sci       Date:  2020-01-21       Impact factor: 6.843

Review 4.  Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases.

Authors:  Kelly M Haston; Steven Finkbeiner
Journal:  Annu Rev Pharmacol Toxicol       Date:  2015-10-28       Impact factor: 13.820

Review 5.  Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery.

Authors:  Alec S T Smith; Jennifer Davis; Gabsang Lee; David L Mack; Deok-Ho Kim
Journal:  Drug Discov Today       Date:  2016-04-22       Impact factor: 7.851

6.  A 1.35 Mb DNA fragment is inserted into the DHMN1 locus on chromosome 7q34-q36.2.

Authors:  Alexander P Drew; Anthony N Cutrupi; Megan H Brewer; Garth A Nicholson; Marina L Kennerson
Journal:  Hum Genet       Date:  2016-08-03       Impact factor: 4.132

7.  Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E.

Authors:  Chiara Pisciotta; Yunhong Bai; Kathryn M Brennan; Xingyao Wu; Tiffany Grider; Shawna Feely; Suola Wang; Steven Moore; Carly Siskind; Michael Gonzalez; Stephan Zuchner; Michael E Shy
Journal:  Neurology       Date:  2015-06-24       Impact factor: 9.910

8.  Altered interplay between endoplasmic reticulum and mitochondria in Charcot-Marie-Tooth type 2A neuropathy.

Authors:  Nathalie Bernard-Marissal; Gerben van Hameren; Manisha Juneja; Christophe Pellegrino; Lauri Louhivuori; Luca Bartesaghi; Cylia Rochat; Omar El Mansour; Jean-Jacques Médard; Marie Croisier; Catherine Maclachlan; Olivier Poirot; Per Uhlén; Vincent Timmerman; Nicolas Tricaud; Bernard L Schneider; Roman Chrast
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-18       Impact factor: 11.205

Review 9.  Axonal transport and neurological disease.

Authors:  James N Sleigh; Alexander M Rossor; Alexander D Fellows; Andrew P Tosolini; Giampietro Schiavo
Journal:  Nat Rev Neurol       Date:  2019-09-26       Impact factor: 42.937

Review 10.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.